Gene: KIF20B
Official Full Name: kinesin family member 20Bprovided by HGNC
Gene Summary: Enables several functions, including ATP hydrolysis activity; WW domain binding activity; and plus-end-directed microtubule motor activity. Involved in positive regulation of cell population proliferation and positive regulation of cytokinesis. Located in several cellular components, including microtubule cytoskeleton; midbody; and nuclear lumen. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06318 | KIF20B Knockout cell line (HeLa) | Human | KIF20B | 1:3~1:6 | Negative | Online Inquiry |
KO06319 | KIF20B Knockout cell line (HCT 116) | Human | KIF20B | 1:2~1:4 | Negative | Online Inquiry |
KO06320 | KIF20B Knockout cell line (HEK293) | Human | KIF20B | 1:3~1:6 | Negative | Online Inquiry |
KO06321 | KIF20B Knockout cell line (A549) | Human | KIF20B | 1:3~1:4 | Negative | Online Inquiry |
KIF20B Gene Knockout Cell Lines are genetically engineered cell lines in which the KIF20B gene, a member of the kinesin motor protein family, has been intentionally disrupted to allow for comprehensive functional studies. The KIF20B protein is primarily associated with cellular processes such as mitosis, particularly in the transport of organelles and the assembly of the mitotic spindle. By utilizing these knockout cell lines, researchers can elucidate the role of KIF20B in cell division, investigate its implications in cancer biology, and explore potential therapeutic targets.
The key mechanism by which KIF20B knockout cell lines operate is through the loss of KIF20B-mediated microtubule dynamics, leading to defects in cell proliferation, checkpoint regulation, and cytokinesis. This disruption enables the direct study of KIF20B's role in these critical cellular processes, allowing scientists to draw critical correlations between KIF20B function and disease states, including tumorigenesis and metastasis.
In terms of scientific importance, these cell lines serve as invaluable tools in research settings, aiding in the dissection of complex cellular pathways involved in cancer and other diseases. Their applications extend to drug discovery, enabling compound screening against a validated target and providing insights into the effectiveness of potential cancer therapeutics.
Compared to alternative gene knockout models, KIF20B Gene Knockout Cell Lines are designed with precision and are rigorously validated for consistent performance, ensuring reproducibility and reliability in experimental results. This enhanced specificity allows researchers to confidently interpret their findings and apply them to real-world clinical challenges.
For researchers and clinicians focused on cancer biology and molecular therapeutics, these knockout cell lines represent a significant advancement. The ability to manipulate gene expression and observe subsequent cellular responses opens new avenues for discovery and innovation. Our company prides itself on delivering high-quality biological products supported by extensive expertise in genetic engineering, ensuring that our offerings meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.